Antibody Discovery Market (Antibody Type: Monoclonal, Polyclonal, and Others; and Service: Phage Display, Hybridoma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Antibody Discovery Market (Antibody Type: Monoclonal, Polyclonal, and Others; and Service: Phage Display, Hybridoma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Antibody Discovery Market – Scope of Report

TMR’s report on the global antibody discovery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global antibody discovery market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global antibody discovery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the antibody discovery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global antibody discovery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global antibody discovery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global antibody discovery market.

The report delves into the competitive landscape of the global antibody discovery market. Key players operating in the global antibody discovery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global antibody discovery market profiled in this report.

Key Questions Answered in Global antibody discovery Market Report
  • What is the sales/revenue generated by antibody discovery across all regions during the forecast period?
  • What are the opportunities in the global antibody discovery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Antibody Discovery Market – Research Objectives and Research Approach

The comprehensive report on the global antibody discovery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global antibody discovery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global antibody discovery market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Antibody Discovery Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Antibody Discovery Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Antibody Discovery Market Analysis and Forecast, by Antibody Type
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Antibody Type, 2020-2034
  6.3.1. Monoclonal
  6.3.2. Polyclonal
  6.3.3. Others
  6.4. Market Attractiveness Analysis, by Antibody Type
7. Global Antibody Discovery Market Analysis and Forecast, by Service
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Service, 2020-2034
  7.3.1. Phage Display
  7.3.2. Hybridoma
  7.3.3. Others
  7.4. Market Attractiveness Analysis, by Service
8. Global Antibody Discovery Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2020-2034
  8.3.1. Pharmaceutical and Biotechnology Companies
  8.3.2. Research Laboratories
  8.3.3. Others
  8.4. Market Attractiveness Analysis, by End-user
9. Global Antibody Discovery Market Analysis and Forecast, by Region
  9.1. Introduction
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by Region, 2020-2034
  9.3.1. North America
  9.3.2. Europe
  9.3.3. Asia Pacific
  9.3.4. Latin America
  9.3.5. Middle East & Africa
  9.4. Market Attractiveness Analysis, by Region
10. North America Antibody Discovery Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Antibody Type, 2020-2034
  10.3.1. Monoclonal
  10.3.2. Polyclonal
  10.3.3. Others
  10.4. Market Value Forecast, by Service, 2020-2034
  10.4.1. Phage Display
  10.4.2. Hybridoma
  10.4.3. Others
  10.5. Market Value Forecast, by End-user, 2020-2034
  10.5.1. Pharmaceutical and Biotechnology Companies
  10.5.2. Research Laboratories
  10.5.3. Others
  10.6. Market Value Forecast, by Country, 2020-2034
  10.6.1. U.S.
  10.6.2. Canada
  10.7. Market Attractiveness Analysis
  10.7.1. By Antibody Type
  10.7.2. By Service
  10.7.3. By End-user
  10.7.4. By Country
11. Europe Antibody Discovery Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Antibody Type, 2020-2034
  11.3.1. Monoclonal
  11.3.2. Polyclonal
  11.3.3. Others
  11.4. Market Value Forecast, by Service, 2020-2034
  11.4.1. Phage Display
  11.4.2. Hybridoma
  11.4.3. Others
  11.5. Market Value Forecast, by End-user, 2020-2034
  11.5.1. Pharmaceutical and Biotechnology Companies
  11.5.2. Research Laboratories
  11.5.3. Others
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.6.1. Germany
  11.6.2. U.K.
  11.6.3. France
  11.6.4. Italy
  11.6.5. Spain
  11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
  11.7.1. By Antibody Type
  11.7.2. By Service
  11.7.3. By End-user
  11.7.4. By Country/Sub-region
12. Asia Pacific Antibody Discovery Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Antibody Type, 2020-2034
  12.3.1. Monoclonal
  12.3.2. Polyclonal
  12.3.3. Others
  12.4. Market Value Forecast, by Service, 2020-2034
  12.4.1. Phage Display
  12.4.2. Hybridoma
  12.4.3. Others
  12.5. Market Value Forecast, by End-user, 2020-2034
  12.5.1. Pharmaceutical and Biotechnology Companies
  12.5.2. Research Laboratories
  12.5.3. Others
  12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.6.1. China
  12.6.2. Japan
  12.6.3. India
  12.6.4. Australia & New Zealand
  12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
  12.7.1. By Antibody Type
  12.7.2. By Service
  12.7.3. By End-user
  12.7.4. By Country/Sub-region
13. Latin America Antibody Discovery Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Antibody Type, 2020-2034
  13.3.1. Monoclonal
  13.3.2. Polyclonal
  13.3.3. Others
  13.4. Market Value Forecast, by Service, 2020-2034
  13.4.1. Phage Display
  13.4.2. Hybridoma
  13.4.3. Others
  13.5. Market Value Forecast, by End-user, 2020-2034
  13.5.1. Pharmaceutical and Biotechnology Companies
  13.5.2. Research Laboratories
  13.5.3. Others
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.6.1. Brazil
  13.6.2. Mexico
  13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
  13.7.1. By Antibody Type
  13.7.2. By Service
  13.7.3. By End-user
  13.7.4. By Country/Sub-region
14. Middle East & Africa Antibody Discovery Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, by Antibody Type, 2020-2034
  14.3.1. Monoclonal
  14.3.2. Polyclonal
  14.3.3. Others
  14.4. Market Value Forecast, by Service, 2020-2034
  14.4.1. Phage Display
  14.4.2. Hybridoma
  14.4.3. Others
  14.5. Market Value Forecast, by End-user, 2020-2034
  14.5.1. Pharmaceutical and Biotechnology Companies
  14.5.2. Research Laboratories
  14.5.3. Others
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.6.1. GCC Countries
  14.6.2. South Africa
  14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
  14.7.1. By Antibody Type
  14.7.2. By Service
  14.7.3. By End-user
  14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
  15.3.1. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  15.3.1.1. Company Overview
  15.3.1.2. Product Portfolio
  15.3.1.3. SWOT Analysis
  15.3.1.4. Financial Overview
  15.3.1.5. Strategic Overview
  15.3.2. Evotec A.G.
  15.3.2.1. Company Overview
  15.3.2.2. Product Portfolio
  15.3.2.3. SWOT Analysis
  15.3.2.4. Financial Overview
  15.3.2.5. Strategic Overview
  15.3.3. Sartorius AG
  15.3.3.1. Company Overview
  15.3.3.2. Product Portfolio
  15.3.3.3. SWOT Analysis
  15.3.3.4. Financial Overview
  15.3.3.5. Strategic Overview
  15.3.4. Charles River Laboratories International, Inc.
  15.3.4.1. Company Overview
  15.3.4.2. Product Portfolio
  15.3.4.3. SWOT Analysis
  15.3.4.4. Financial Overview
  15.3.4.5. Strategic Overview
  15.3.5. Creative Biolabs, Inc.
  15.3.5.1. Company Overview
  15.3.5.2. Product Portfolio
  15.3.5.3. SWOT Analysis
  15.3.5.4. Financial Overview
  15.3.5.5. Strategic Overview
  15.3.6. Bruker Cellular Analysis, Inc.
  15.3.6.1. Company Overview
  15.3.6.2. Product Portfolio
  15.3.6.3. SWOT Analysis
  15.3.6.4. Financial Overview
  15.3.6.5. Strategic Overview
  15.3.7. BioDuro LLC
  15.3.7.1. Company Overview
  15.3.7.2. Product Portfolio
  15.3.7.3. SWOT Analysis
  15.3.7.4. Financial Overview
  15.3.7.5. Strategic Overview
  15.3.8. Aragen Life Sciences
  15.3.8.1. Company Overview
  15.3.8.2. Product Portfolio
  15.3.8.3. SWOT Analysis
  15.3.8.4. Financial Overview
  15.3.8.5. Strategic Overview
  15.3.9. Abzena
  15.3.9.1. Company Overview
  15.3.9.2. Product Portfolio
  15.3.9.3. SWOT Analysis
  15.3.9.4. Financial Overview
  15.3.9.5. Strategic Overview
  15.3.10. AbTherx
  15.3.10.1. Company Overview
  15.3.10.2. Product Portfolio
  15.3.10.3. SWOT Analysis
  15.3.10.4. Financial Overview
  15.3.10.5. Strategic Overview
  15.3.11. Sanyou Biopharmaceuticals Co., Ltd.
  15.3.11.1. Company Overview
  15.3.11.2. Product Portfolio
  15.3.11.3. SWOT Analysis
  15.3.11.4. Financial Overview
  15.3.11.5. Strategic Overview
  15.3.12. Other Prominent Players
  15.3.12.1. Company Overview
  15.3.12.2. Product Portfolio
  15.3.12.3. SWOT Analysis
  15.3.12.4. Financial Overview
  15.3.12.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings